iGlobe Partners — 2021 Investments
1 investments dated 2021 · listed companies and verified rows first · show all
C2i Genomicsc2i-genomics.comin𝕏Apr 2021 · $100MAcquired
C2i Genomics develops a whole-genome sequencing platform that uses AI algorithms to build patient-specific cancer signatures for detecting minimal residual disease (MRD) and monitoring cancer.
AI & Machine LearningBiotechDigital HealthHealthtechNew York, US
Asaf Zviran(Founder)inEzra Sofer(Executive Officer, Director)
BoardEli Casdin(Director)inAlex Parker(Director)Shaun Rodriguez(Director)in
Co-investorsLionBirdNat TurnerNFXCasdin CapitalSection 32
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.





